Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are over 18 years old
- People who have been diagnosed with a typical or atypical form of Parkinson's disease, which may include conditions such as Multiple System Atrophy, Pure Autonomic Failure, or Progressive Supranuclear Palsy
- People who have a confirmed drop in blood pressure when standing up, shown through a specific standing test
- People whose blood pressure drop when standing causes significant difficulties with everyday activities, as assessed by the study doctors
- People who are willing and able to sign a consent form before any study procedures begin
- People whose overall medical, physical, and psychological health is considered stable enough by the study team
- People who are able to communicate in French or English with the study team
- People who are willing to follow all study requirements and attend all scheduled visits
Who may not be able to join:
- People who have health conditions that would make the implantation surgery more risky or dangerous
- People who are unable to temporarily stop taking blood-thinning or anti-clotting medications around the time of surgery
- People who have had a heart attack or stroke within the past 6 months
- People who have an unstable or significant health condition that could interfere with the study or make the results harder to interpret, as decided by the study doctor
- People who have a history of, or are currently experiencing, a major psychiatric condition or significant problems with memory and thinking, as assessed by the study team together with the treating doctor and neurologist
- People who have major changes to their Parkinson's disease treatment planned before the end of the main study phase, such as deep brain stimulation or a dopamine pump
- People who are unable to follow the study procedures
- People who have abnormalities in their spine that would prevent surgery
- People who have a condition that requires frequent MRI scans
- People who are currently pregnant or breastfeeding
- Women of childbearing age who do not have an effective or acceptable form of contraception
- People who intend to become pregnant during the study
- People who are unable or unwilling to use the study device or related equipment, as determined by the study team
- People who are already taking part in another interventional study that could affect the results of this trial
- The investigators running the trial, along with their family members, employees, or other dependants
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jocelyne Bloch, MD, CHUV
Phone: +41 21 69 30762
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Occurrence of (serious) adverse device effects of the ARC-IM Therapy from baseline up to the end of the study.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.